Sarepta Therapeutics saw its stock skid 11% after the company announced preliminary unaudited 2025 sales results that missed analyst forecasts for its marketed Elevidys® (delandistrogene ...
Stopping cancer cells from entering a soft biomechanical state could help the immune system clear dormant cancer metastasis.
Researchers suggest that wound dressings infused with antioxidants such as catalase could be an effective future treatment.